SCHEMBL8315359

SCHEMBL8315359

CC(=O)N1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(C(C)C)cc4)n3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 3/20 0.55
CDK1 P06493 2/20 0.55
JAK2 O60674 8/20 0.50
JAK3 P52333 4/20 0.50
IKBKB O14920 2/20 0.50
CHUK O15111 2/20 0.50
CAMK2D Q13557 2/20 0.49
SYK P43405 2/20 0.48
AURKA O14965 2/20 0.48
CDK4 P11802 2/20 0.48
CDK7 P50613 2/20 0.48
CDK9 P50750 2/20 0.48
AURKB Q96GD4 2/20 0.48
IKBKG Q9Y6K9 1/20 0.48
HDAC3 O15379 1/20 0.48
NCOR1 O75376 1/20 0.48
JAK1 P23458 1/20 0.48
TYK2 P29597 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14063806 0.91 IKBKB (0.51) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL1512786 0.90 PIK3CA (0.55) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL4062587 0.90 PLK4 (0.55) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL8215036 0.89 MKNK1 (0.54) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL8205109 0.89 CDK2 (0.55) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL8312330 0.88 JAK2 (0.52) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL14020993 0.88 PIK3CA (0.55) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL8307949 0.88 MAPK8 (0.63) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL14021253 0.87 IKBKB (0.52) CDK2CDK1JAK2JAK3IKBKB
SCHEMBL14063804 0.86 CDK2 (0.51) CDK2CDK1JAK2JAK3IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed